Secretary to GM - WOW! HA HA HA - THE "HAMMER" TMISS

ASSISTANT BEFORE GM. SALES REP 5-6 YEARS AGO.
NO EXPERIENCE AND THIS IS A COMPLETE JOKE

Vice President and General Manager, Neurology
Mallinckrodt Pharmaceuticals
May 2015 – Present (4 months)Hayward, CA
Full general management responsibilities for Mallinckrodt's $300M+ neurology business, including Acthar H.P. Gel and Gablofen.
Responsible for providing leadership guidance and strong executional focus to sales and marketing functions and ensuring cross-functional alignment in support of the business.

Vice President and General Manager, Intrathecal Therapies
Mallinckrodt Pharmaceuticals
February 2014 – May 2015 (1 year 4 months)Greater St. Louis Area

Sr. Staff Liaison to the CEO
Mallinckrodt
March 2012 – January 2014 (1 year 11 months)
Provide project management support for the President/CEO and his executive team by providing oversight, advice and guidance on initiatives of high importance and visibility. Collaborates closely with the President/CEO to plan, coordinate and review materials related to the strategic direction of the business.

Director, Marketing
Mallinckrodt
October 2011 – March 2012 (6 months)St. Louis, MO

Sales Director - Americas
Covidien
October 2009 – October 2011 (2 years 1 month)

Field Sales Representative
Covidien
May 2007 – October 2009 (2 years 6 months)New Jersey

Product Manager
Covidien
September 2004 – May 2007 (2 years 9 months)St. Louis, MO

Quality Lab Manager
Tyco Healthcare
November 2000 – September 2004 (3 years 11 months)St. Louis, MO

Quality Analyst
Mallinckrodt
January 2000 – November 2000 (11 months)St. Louis, MO

 

Ha ha...someone likes my nickname for him the hammer....or puppet. Hugh,Mark will use this "yes" boy to deliver to us all the bad news from the Malli gods above and get rid of us all eventually.

 

Can't eliminate the team... Wallstreet is watch every twitch of ARD sales and news around the investigation. They are trying their best to restore the growth trajectory and at least increase net income by cutting costs during the sales "stall". Not a bad call to have minimal presence at ACR just please don't cut funding to regional and state meetings. The new data sets might stimulate team to "sell". Biggest problem going forward is lack of leadership. Need someone in charge who has a clue and appreciates the value of those generating the sales.